US equities |
AAPL $349.51 ▲+5.31% NVDA $200.13 ▼-3.17% MU $795.23 ▼-7.00% MSFT $555.80 ▲+6.68% AMD $488.78 ▲+1.01% AMZN $266.03 ▲+6.12% META $630.00 ▲+1.44% TSLA $385.19 ▼-3.34%
FinancialContent

Verastem, Inc. - Common Stock (NQ:VSTM)

9.850 +0.080 (+0.82%)
Delayed Quote Updated: 4:00 PM EST, Nov 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Verastem, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer
From Verastem Oncology
Via Business Wire
News headline image
Why Verastem Stock Spiked Today ↗
A clinical collaboration with biotech titan Amgen briefly lit a fire underneath Verastem's shares today. 
Via The Motley Fool
News headline image
Why Verastem Shares Are Trading Higher Today ↗
Verastem Inc (NASDAQ: VSTM) is trading higher Monday after the company announced updated investigator-sponsored Phase 1/2 FRAME study data of VS-6766 with defactinib in low-... 
Via Benzinga
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 30.6% to $7.68 after the company... 
Via Benzinga
News headline image
Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher ↗
Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN). 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million.... 
Via Benzinga
News headline image
24 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Verastem, Inc. (NASDAQ: VSTM) rose 30.8% to $3.61 in pre-market trading after the company announced a mini oral presentation highlighting updated data from the ongoing... 
Via Benzinga
News headline image
Verastem Oncology and Amgen Partner to Evaluate VS-6766 in Combination with LUMAKRASTM (Sotorasib) in Patients with KRAS G12C-Mutant Non-Small Cell Lung Cancer
From Verastem Oncology
Via Business Wire
News headline image
Verastem Shares Are Trading Higher On Encouraging Combo Therapy Data At ESMO Presentation ↗
Verastem Oncology Inc (NASDAQ: VSTM) stock is trading higher after updated data from the ongoing Phase 1/2 FRAME study. The investigator-sponsored study is... 
Via Benzinga
News headline image
Verastem Oncology Announces Updated Investigator-Sponsored Phase 1/2 FRAME Study Data of VS-6766 with Defactinib in Low-Grade Serous Ovarian Cancer Showing Encouraging Response Rates and Progression-Free Survival Presented at ESMO 2021
From Verastem Oncology
Via Business Wire
News headline image
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight ↗
Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical... 
Via Benzinga
News headline image
Verastem Oncology to Present at Upcoming Investor Conferences
From Verastem Oncology
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Outlook Therapeutics (NASDAQ:OTLK) shares increased by 38.49% to $3.13 during Tuesday's pre-market session. The company's market cap stands at $543.3... 
Via Benzinga
News headline image
Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
From Verastem Oncology
Via Business Wire
News headline image
Verastem Oncology Announces Updated Phase 1/2 FRAME Study Data in Low Grade Serous Ovarian Cancer Selected for a Mini Oral Presentation at the European Society of Medical Oncology Congress 2021
From Verastem Oncology
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The company's market cap stands at $31.4 million.... 
Via Benzinga
News headline image
Verastem Oncology Announces Conversion of Senior Notes Eliminating Substantially All Outstanding Debt
From Verastem Oncology
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life... 
Via Benzinga
News headline image
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Verastem Oncology
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021 ↗
Upgrades Citigroup upgraded the previous rating for Thor Industries Inc (NYSE: 
Via Benzinga
News headline image
Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors
From Verastem Oncology
Via Business Wire
News headline image
44 Biggest Movers From Yesterday ↗
Gainers Alfi, Inc. (NASDAQ: ALF) shares jumped 108.9% to settle at $16.29 on Tuesday following exclusive Benzinga reporting the company will buyback up to $2 million of its... 
Via Benzinga
News headline image
2 Biotech Penny Stocks That Are Vastly Superior Investments to Dogecoin ↗
These unloved cancer stocks should dramatically outperform Dogecoin over the long haul. 
Via The Motley Fool
News headline image
Stocks That Hit 52-Week Highs On Wednesday ↗
Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs. Interesting Facts: Toyota Motor (NYSE:TM) was the largest firm by market cap to set a new 52-... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers NeuroMetrix (NASDAQ:NURO) stock r... 
Via Benzinga
News headline image
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Agios Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Monday ↗
During Monday's morning session, 255 companies made new 52-week highs. Points of Interest: The largest company by market cap to set a new 52-week high was Adobe (... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Wednesday ↗
During Wednesday's morning trading, 251 companies set new 52-week highs. Areas of Interest: Alphabet (NASDAQ:GOOG) was the company with the largest market cap... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Tuesday ↗
Tuesday morning saw 244 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >